1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with alpha-bulnesene in 1 studies
Studies (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Trials (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Recent Studies (post-2010) (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Studies (alpha-bulnesene) | Trials (alpha-bulnesene) | Recent Studies (post-2010) (alpha-bulnesene) |
---|---|---|---|---|---|
9,156 | 187 | 552 | 9 | 0 | 7 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chen, CC; Hsu, HC; Huang, HY; Tsai, WJ; Tsai, YC; Yang, WC | 1 |
1 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and alpha-bulnesene
Article | Year |
---|---|
Alpha-bulnesene, a novel PAF receptor antagonist isolated from Pogostemon cablin.
Topics: Animals; Arachidonic Acid; Blood Platelets; Calcium; Dose-Response Relationship, Drug; Inhibitory Concentration 50; Models, Chemical; Plant Extracts; Platelet Activating Factor; Platelet Aggregation; Platelet Membrane Glycoproteins; Rabbits; Receptors, G-Protein-Coupled; Sesquiterpenes; Sesquiterpenes, Guaiane; Thromboxanes | 2006 |